Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.
Program Director, Clinical and Translational Epidemiology Branch
Contact Information
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Blvd., Rm. 5130, MSC 7393
Bethesda, MD 20892-7393
(For express delivery, use Rockville, MD 20852)
telephone: (301) 594-6809
fax: (301) 435-6609
e-mail: nshelburne@mail.nih.gov
Interest Areas
Benefit-risk prediction models for clinical oncology practice related to cancer treatment outcomes and toxicity.
Degrees
M.S. - Advanced Practice Oncology Nursing
University of Maryland at Baltimore School of Nursing
B.S. - Nursing
University of Maryland at Baltimore School of Nursing
Biography
Ms. Shelburne is a Program Director in the Epidemiology and Genomics Research Program's (EGRP) Clinical and Translational Epidemiology Branch (CTEB). She is responsible for developing research consortia and benefit-risk prediction models related to cancer treatment outcomes and toxicity. She also has an adjunct research appointment focusing on problem solving interventions and quality of life trials within the Blood and Marrow Transplant population at the NIH Clinical Center.
Before joining EGRP in 2010, Ms. Shelburne was an Acute Care Nurse Practitioner and Oncology Clinical Nurse Specialist with the Hematology and Stem Cell Transplant Program of Care at the NIH Clinical Center. From 1998-2004, she was a Clinical Research Nurse within the same program. Her focus was on improving the clinical and research outcomes of patients in phase I and II clinical trials for cancer and hematological disorders. Ms. Shelburne was an Associate Investigator on clinical trials, and served as Chair of the NIH Bone Marrow Transplant Consortium (BMT) and Research Participant Education Committee. Her other interests included development of the Fall Risk Prevention Program for the NIH Clinical Center, development of an algorithm for predicting delirium development in the BMT population, understanding endocrine late effects after blood and marrow transplant, and educating physicians, nurses, and research participants on cancer care and treatment.
Ms. Shelburne is an Advanced Oncology Certified Nurse (A.O.C.N.) and a Certified Registered Nurse Practitioner (C.R.N.P.) in Acute Care Oncology.
